Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-11 Sale |
2022-11-15 8:00 pm |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
41,666 | $5.1525 | $214,685 | 778,353 (Direct) |
View |
| 2021-12-20 Purchase |
2021-12-21 9:41 pm |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
12,000 | $8.5663 | $102,796 | 23,295 (Direct) |
View |
| 2020-11-03 Purchase |
2020-11-04 4:05 pm |
Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
250,000 | $24 | $6,000,000 | 289,695 (Indirect) |
View |
| 2020-11-03 Purchase |
2020-11-03 9:36 pm |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
250,000 | $24 | $6,000,000 | 5,615,659 (Indirect) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:09 pm |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
41,666 | $24 | $999,984 | 820,019 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-01-31 Option Award |
2023-02-02 6:30 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
319,400 | $0 | 319,400 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:28 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
337,000 | $0 | 337,000 (Direct) |
View |
| 2023-01-31 Option Award |
2023-02-02 6:26 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
240,000 | $0 | 240,000 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:49 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:48 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:47 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:47 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:45 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 7:45 pm |
N/A 2032-06-16 |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
61,264 | $0 | 61,264 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne EVP, Chief Accounting Officer |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
170,000 | $0 | 170,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
378,033 | $0 | 378,033 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
181,000 | $0 | 181,000 (Direct) |
View |
| 2022-01-31 Option Award |
2022-02-02 5:15 pm |
N/A 2032-01-30 |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:36 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:36 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:35 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:34 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-21 5:30 pm |
N/A 2031-06-17 |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
34,025 | $0 | 34,025 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-20 6:27 pm |
N/A 2031-05-17 |
Atea Pharmaceuticals Inc. | AVIR | Adams Jerome M. Director |
56,670 | $0 | 56,670 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:56 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
640,000 | $0 | 640,000 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:55 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
160,050 | $0 | 160,050 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:52 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
148,850 | $0 | 148,850 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:51 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
117,300 | $0 | 117,300 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:51 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Chief Medical Officer |
145,500 | $0 | 145,500 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-01 4:50 pm |
N/A 2031-01-28 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
71,750 | $0 | 71,750 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-05 4:01 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua Cormorant Private Healthcare Fund II LP Cormorant Global Healthcare Master Fund LP CORMORANT PRIVATE HEALTHCARE FUND I LP Former 10% Owner |
12,822,710 | $0 | 6,411,355 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-04 4:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
3,388,838 | $0 | 289,695 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 9:36 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
10,731,318 | $0 | 5,615,659 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:09 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
22,590 | $0 | 11,295 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:09 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
1,519,212 | $0 | 820,019 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
266,008 | $0 | 633,004 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
750,000 | $0 | 5,925,000 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner |
353,724 | $0 | 1,176,862 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:04 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
82,508 | $0 | 82,508 (Indirect) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:49 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
80,000 | $0 | 80,000 (Direct) |
View |